Cholangiocarcinoma | sciencenewsnet.in

Breaking News

ADDMAN Secures Qualification Project for CuNi Submarine Fittings with the US Navy

It’s easier now to treat opioid addiction with medication — but use has changed little

Researchers Publish Final Results of Key Clinical Trial for Gene Therapy for Sickle Cell Disease

A new report from the American Lung Association shows nearly 40% of people across the U.S. are living in areas that are heavily polluted.

Five facilities at Argonne where climate solutions are front and center

Use of Acid Reflux Drugs Linked to Higher Risk of Migraine

For Immigrants to Canada, Risk of MS Increases with Proportion of Life Spent There

Sweet potato quality analysis is enhanced with hyperspectral imaging and AI

The Medical Minute: Supervised exercise therapy eases symptoms of peripheral artery disease

Detection of Missed Colorectal Cancer Remains Low for Most Diverticulitis Patients

25 Apr, 2024

Targeted Chemotherapy Helps Cure Some Inoperable Tumors

June 14, 2023 sarah JonasFeature Expert

Physicians at Cedars-Sinai Cancer are using a unique chemotherapy delivery system that offers hope to colorectal cancer patients whose disease has spread and who now have inoperable liver tumors. Cedars-Sinai is one of the few centers in the area to offer the therapy, called hepatic artery infusion (HAI) pump chemotherapy.

MD Anderson Research Highlights for September 22, 2021

September 22, 2021 sarah JonasResearch Tip Sheet

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, translational and clinical cancer research from MD Anderson experts. Current advances include a new method to measure breast cancer response, a new immunotherapy approach for multiple myeloma, characterization of the immune landscape of cholangiocarcinoma, a new contrast agent to improve molecular imaging techniques, and new treatment targets in breast, gynecologic and pancreatic cancers.